Cargando…
The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab
PURPOSE: The purpose of this study is to evaluate the effect of complement factor H (CFH) Y402H CC and TT polymorphisms on treatment response to intravitreal ranibizumab injection in patients with wet age-related macular degeneration (AMD). METHODS: One hundred ninety-three patients with choroidal n...
Autores principales: | Dikmetas, Ozlem, Kadayıfcılar, Sibel, Eldem, Bora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3869644/ https://www.ncbi.nlm.nih.gov/pubmed/24367156 |
Ejemplares similares
-
Ranibizumab therapy for predominantly hemorrhagic neovascular age-related macular degeneration
por: Dikmetas, Ozlem, et al.
Publicado: (2022) -
Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
por: Otsuji, Tsuyoshi, et al.
Publicado: (2013) -
Association between Variant Y402H in Age-Related Macular Degeneration (AMD) Susceptibility Gene CFH and Treatment Response of AMD: A Meta-Analysis
por: Chen, Han, et al.
Publicado: (2012) -
Switching from Intravitreal Ranibizumab to Bevacizumab for
Age-Related Macular Degeneration
por: Yamada, Kisaburo, et al.
Publicado: (2011) -
Associations of ARMS2 and CFH Gene Polymorphisms with Neovascular Age-Related Macular Degeneration
por: Supanji, Supanji, et al.
Publicado: (2021)